US Stock MarketDetailed Quotes

Alnylam Pharmaceuticals (ALNY)

Watchlist
  • 362.935
  • -7.065-1.91%
Trading Jan 23 11:55 ET
47.95BMarket Cap1209.78P/E (TTM)

Alnylam Pharmaceuticals (ALNY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
149.35%1.25B
17.26%773.69M
20.20%594.19M
22.97%2.25B
34.90%593.17M
-33.26%500.92M
107.00%659.83M
54.82%494.33M
76.23%1.83B
31.25%439.72M
Operating revenue
149.35%1.25B
17.26%773.69M
20.20%594.19M
22.97%2.25B
34.90%593.17M
-33.26%500.92M
107.00%659.83M
54.82%494.33M
76.23%1.83B
31.25%439.72M
Cost of revenue
132.99%200.15M
108.17%142.95M
7.68%71.04M
4.18%323.37M
19.75%102.82M
1.89%85.91M
-19.56%68.67M
20.24%65.98M
83.87%310.41M
67.48%85.86M
Gross profit
152.73%1.05B
6.70%630.74M
22.13%523.15M
26.81%1.92B
38.57%490.35M
-37.71%415.01M
153.30%591.15M
62.00%428.36M
74.75%1.52B
24.70%353.86M
Operating expense
38.42%680.89M
19.24%646.94M
7.05%505.07M
16.76%2.1B
26.63%595.51M
8.75%491.92M
17.12%542.54M
13.90%471.79M
8.85%1.8B
-0.45%470.26M
Selling and administrative expenses
45.74%322.08M
30.16%323.31M
13.83%239.95M
22.61%975.53M
49.07%295.34M
10.95%220.99M
15.70%248.4M
14.78%210.8M
3.24%795.65M
-5.81%198.12M
-General and administrative expense
45.74%322.08M
30.16%323.31M
13.83%239.95M
22.61%975.53M
49.07%295.34M
10.95%220.99M
15.70%248.4M
14.78%210.8M
3.24%795.65M
-5.81%198.12M
Research and development costs
32.44%358.81M
10.02%323.62M
1.58%265.12M
12.13%1.13B
10.30%300.17M
7.01%270.93M
18.35%294.14M
13.20%261M
13.75%1B
3.86%272.14M
Operating profit
578.49%367.98M
-133.32%-16.2M
141.62%18.08M
37.31%-176.89M
9.66%-105.16M
-135.96%-76.91M
121.15%48.61M
71.01%-43.44M
64.06%-282.18M
38.28%-116.4M
Net non-operating interest income expense
-604.80%-15.72M
-213.05%-12.76M
-77.84%-9.97M
22.58%-19.87M
-753.22%-7.95M
59.22%-2.23M
54.51%-4.08M
45.55%-5.61M
80.44%-25.66M
94.11%-932K
Non-operating interest income
-10.78%28.68M
-5.81%27.49M
-3.28%28.67M
27.66%121.99M
2.02%31.02M
26.43%32.15M
38.47%29.18M
58.91%29.65M
285.20%95.56M
116.00%30.41M
Non-operating interest expense
29.15%44.4M
21.01%40.25M
9.62%38.65M
17.02%141.86M
24.36%38.97M
11.27%34.38M
10.73%33.26M
21.75%35.25M
-22.28%121.22M
4.76%31.34M
Other net income (expense)
-283.69%-113.3M
88.51%-6.4M
-241.72%-49.7M
-43.72%-180.62M
-297.26%-80.85M
48.79%-29.53M
-57.28%-55.71M
-18.68%-14.54M
40.37%-125.68M
-691.56%-20.35M
Gain on sale of security
-70.89%-64.66M
70.87%-16.61M
-603.42%-59.85M
-61.01%-173.79M
-215.37%-70.44M
21.26%-37.84M
-97.84%-57.01M
2.63%-8.51M
15.65%-107.94M
-30.71%-22.34M
Special income (charges)
---39.15M
----
----
--0
--0
--0
----
----
--0
----
-Less:Other special charges
--39.15M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-214.18%-9.49M
682.98%10.21M
268.11%10.15M
61.49%-6.83M
-624.70%-10.41M
186.52%8.31M
119.75%1.3M
-71.62%-6.04M
-185.96%-17.74M
-86.33%1.98M
Income before tax
319.92%238.97M
-216.63%-35.36M
34.58%-41.6M
12.95%-377.38M
-40.87%-193.96M
-172.09%-108.66M
95.93%-11.17M
63.11%-63.59M
61.53%-433.52M
33.49%-137.69M
Income tax
-516.75%-12.12M
440.35%30.92M
576.45%15.88M
-1,575.36%-99.22M
-60,315.85%-110.2M
-2.71%2.91M
215.26%5.72M
35.02%2.35M
61.54%6.73M
-61.23%183K
Net income
325.05%251.08M
-292.43%-66.28M
12.82%-57.48M
36.82%-278.16M
39.24%-83.76M
-175.51%-111.57M
93.88%-16.89M
62.13%-65.94M
61.08%-440.24M
33.55%-137.87M
Net income continuous Operations
325.05%251.08M
-292.43%-66.28M
12.82%-57.48M
36.82%-278.16M
39.24%-83.76M
-175.51%-111.57M
93.88%-16.89M
62.13%-65.94M
61.08%-440.24M
33.55%-137.87M
Minority interest income
Net income attributable to the parent company
325.05%251.08M
-292.43%-66.28M
12.82%-57.48M
36.82%-278.16M
39.24%-83.76M
-175.51%-111.57M
93.88%-16.89M
62.13%-65.94M
61.08%-440.24M
33.55%-137.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
325.05%251.08M
-292.43%-66.28M
12.82%-57.48M
36.82%-278.16M
39.24%-83.76M
-175.51%-111.57M
93.88%-16.89M
62.13%-65.94M
61.08%-440.24M
33.55%-137.87M
Basic earnings per share
319.54%1.91
-292.31%-0.51
15.38%-0.44
38.07%-2.18
40.91%-0.65
-173.73%-0.87
94.12%-0.13
62.86%-0.52
62.15%-3.52
34.52%-1.1
Diluted earnings per share
311.49%1.84
-292.31%-0.51
15.38%-0.44
38.07%-2.18
40.91%-0.65
-175.65%-0.87
94.12%-0.13
62.86%-0.52
62.15%-3.52
34.52%-1.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 149.35%1.25B17.26%773.69M20.20%594.19M22.97%2.25B34.90%593.17M-33.26%500.92M107.00%659.83M54.82%494.33M76.23%1.83B31.25%439.72M
Operating revenue 149.35%1.25B17.26%773.69M20.20%594.19M22.97%2.25B34.90%593.17M-33.26%500.92M107.00%659.83M54.82%494.33M76.23%1.83B31.25%439.72M
Cost of revenue 132.99%200.15M108.17%142.95M7.68%71.04M4.18%323.37M19.75%102.82M1.89%85.91M-19.56%68.67M20.24%65.98M83.87%310.41M67.48%85.86M
Gross profit 152.73%1.05B6.70%630.74M22.13%523.15M26.81%1.92B38.57%490.35M-37.71%415.01M153.30%591.15M62.00%428.36M74.75%1.52B24.70%353.86M
Operating expense 38.42%680.89M19.24%646.94M7.05%505.07M16.76%2.1B26.63%595.51M8.75%491.92M17.12%542.54M13.90%471.79M8.85%1.8B-0.45%470.26M
Selling and administrative expenses 45.74%322.08M30.16%323.31M13.83%239.95M22.61%975.53M49.07%295.34M10.95%220.99M15.70%248.4M14.78%210.8M3.24%795.65M-5.81%198.12M
-General and administrative expense 45.74%322.08M30.16%323.31M13.83%239.95M22.61%975.53M49.07%295.34M10.95%220.99M15.70%248.4M14.78%210.8M3.24%795.65M-5.81%198.12M
Research and development costs 32.44%358.81M10.02%323.62M1.58%265.12M12.13%1.13B10.30%300.17M7.01%270.93M18.35%294.14M13.20%261M13.75%1B3.86%272.14M
Operating profit 578.49%367.98M-133.32%-16.2M141.62%18.08M37.31%-176.89M9.66%-105.16M-135.96%-76.91M121.15%48.61M71.01%-43.44M64.06%-282.18M38.28%-116.4M
Net non-operating interest income expense -604.80%-15.72M-213.05%-12.76M-77.84%-9.97M22.58%-19.87M-753.22%-7.95M59.22%-2.23M54.51%-4.08M45.55%-5.61M80.44%-25.66M94.11%-932K
Non-operating interest income -10.78%28.68M-5.81%27.49M-3.28%28.67M27.66%121.99M2.02%31.02M26.43%32.15M38.47%29.18M58.91%29.65M285.20%95.56M116.00%30.41M
Non-operating interest expense 29.15%44.4M21.01%40.25M9.62%38.65M17.02%141.86M24.36%38.97M11.27%34.38M10.73%33.26M21.75%35.25M-22.28%121.22M4.76%31.34M
Other net income (expense) -283.69%-113.3M88.51%-6.4M-241.72%-49.7M-43.72%-180.62M-297.26%-80.85M48.79%-29.53M-57.28%-55.71M-18.68%-14.54M40.37%-125.68M-691.56%-20.35M
Gain on sale of security -70.89%-64.66M70.87%-16.61M-603.42%-59.85M-61.01%-173.79M-215.37%-70.44M21.26%-37.84M-97.84%-57.01M2.63%-8.51M15.65%-107.94M-30.71%-22.34M
Special income (charges) ---39.15M----------0--0--0----------0----
-Less:Other special charges --39.15M------------------------------------
Other non- operating income (expenses) -214.18%-9.49M682.98%10.21M268.11%10.15M61.49%-6.83M-624.70%-10.41M186.52%8.31M119.75%1.3M-71.62%-6.04M-185.96%-17.74M-86.33%1.98M
Income before tax 319.92%238.97M-216.63%-35.36M34.58%-41.6M12.95%-377.38M-40.87%-193.96M-172.09%-108.66M95.93%-11.17M63.11%-63.59M61.53%-433.52M33.49%-137.69M
Income tax -516.75%-12.12M440.35%30.92M576.45%15.88M-1,575.36%-99.22M-60,315.85%-110.2M-2.71%2.91M215.26%5.72M35.02%2.35M61.54%6.73M-61.23%183K
Net income 325.05%251.08M-292.43%-66.28M12.82%-57.48M36.82%-278.16M39.24%-83.76M-175.51%-111.57M93.88%-16.89M62.13%-65.94M61.08%-440.24M33.55%-137.87M
Net income continuous Operations 325.05%251.08M-292.43%-66.28M12.82%-57.48M36.82%-278.16M39.24%-83.76M-175.51%-111.57M93.88%-16.89M62.13%-65.94M61.08%-440.24M33.55%-137.87M
Minority interest income
Net income attributable to the parent company 325.05%251.08M-292.43%-66.28M12.82%-57.48M36.82%-278.16M39.24%-83.76M-175.51%-111.57M93.88%-16.89M62.13%-65.94M61.08%-440.24M33.55%-137.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 325.05%251.08M-292.43%-66.28M12.82%-57.48M36.82%-278.16M39.24%-83.76M-175.51%-111.57M93.88%-16.89M62.13%-65.94M61.08%-440.24M33.55%-137.87M
Basic earnings per share 319.54%1.91-292.31%-0.5115.38%-0.4438.07%-2.1840.91%-0.65-173.73%-0.8794.12%-0.1362.86%-0.5262.15%-3.5234.52%-1.1
Diluted earnings per share 311.49%1.84-292.31%-0.5115.38%-0.4438.07%-2.1840.91%-0.65-175.65%-0.8794.12%-0.1362.86%-0.5262.15%-3.5234.52%-1.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More